Loading...
Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
Objective: Evaluate the safety of albuterol multidose dry powder inhaler (MDPI), a novel, inhalation-driven device that does not require coordination of actuation with inhalation, in patients with persistent asthma. Methods: We report pooled safety data from two 12-week, multicenter, randomized, dou...
Na minha lista:
| Udgivet i: | J Asthma |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4819808/ https://ncbi.nlm.nih.gov/pubmed/26369589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02770903.2015.1070862 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|